Landmark vs Ultrasound For Combined Spinal Epidural
Launched by SAKARYA UNIVERSITY · May 22, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two methods for placing a special type of anesthesia called a combined spinal epidural (CSEA) in obese patients who need orthopedic surgery on their legs. The goal is to find out which method is more effective: using a technique based on anatomical landmarks (the visible parts of the body) or using ultrasound (a special imaging technique) to guide the placement of the anesthesia catheter. The study will include 60 patients aged 40 to 80 who have a Body Mass Index (BMI) over 30 and are scheduled for elective surgery.
To participate in this trial, patients must be in good health (ASA II-III) and have a BMI greater than 30. Those who have certain medical conditions, such as severe scoliosis or who do not agree to join the study, will not be eligible. Participants can expect to be assigned to one of two groups: one will have the catheter placement guided by ultrasound, while the other will have it done by feeling the body’s landmarks. The researchers will compare how successful each method is in placing the catheter on the first try, how many attempts are needed, and if there are any complications. This study aims to improve the anesthesia experience for obese patients undergoing surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA II-III
- • BMI\>30
- • Elective orthopedic lower extremity surgery
- • Combined spinal epidural anesthesia (CSEA)
- Exclusion Criteria:
- • Patients with CSEA contraindication
- • ASA IV-V
- • Diagnosed with scoliosis
- • Patients with anatomical disorders
- • Patients who did not agree to participate in the study
- • Patients for whom follow-up conditions could not be met
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported